optimizing car-t therapy for patients with multiple myeloma in the real-world
Published 1 year ago • 59 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
2:57
strategies to optimize car-t therapy in myeloma: bringing car-t into earlier lines
-
3:06
management of multiple myeloma during car-t therapy manufacturing
-
3:03
the future of car-t therapy for multiple myeloma
-
1:49
rehabilitation needs of patients with multiple myeloma undergoing car-t therapy
-
1:47
clinical outcomes of patients with r/r multiple myeloma listed for treatment with car-t therapy
-
5:25
how to optimize car-t therapy for all
-
1:43
improving the qol of patients with multiple myeloma treated with car-t therapy
-
27:14
optimizing brain health with cutting-edge therapies, peptides and more
-
4:21
an insight into the changing role of transplantation for myeloma & lymphoma in the era of car-t
-
1:38
challenges of car-t therapy in the real-world setting
-
1:38
how to optimize access to car-t cell therapies in multiple myeloma
-
14:10
highlights in multiple myeloma: improving access to car-t therapy, novel targets & future outlooks
-
1:54
ongoing car-t trials in earlier lines of therapy in myeloma & strategies to improve efficacy
-
1:07
optimizing car-t therapy: regulating car t-cells in vivo
-
2:49
novel strategies to optimize car-t therapy in myeloma
-
2:21
the potential of cs1-targeted car-t therapy in multiple myeloma
-
9:58
the management & optimization of car t-cell therapy in myeloma
-
2:00
the value of car-t cell therapy for the treatment of r/r multiple myeloma
-
1:22
the potential use of car-t therapy following autologous transplantation in multiple myeloma